Pavlos Papakostas

Paclitaxel Plus Carboplatin Versus Gemcitabine Plus Paclitaxel in Advanced Non–Small-Cell Lung Cancer: A Phase III Randomized Trial

P. Kosmidis, Nick Mylonakis, C. Nicolaides et al. · Journal of Clinical Oncology · 2002 · 255 citations

Medicine, Oncology, Pharmacology +17

Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group

Aristotelis Bamias, Gerasimos Aravantinos, C. Deliveliotis et al. · Journal of Clinical Oncology · 2003 · 188 citations · Full text

Pharmacy, Oncology, Pharmacology +15

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

Evangelia Razis, Mattheos Bobos, Vassiliki Kotoula et al. · Breast Cancer Research and Treatment · 2011 · 177 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

C. Christodoulou, Dimitrios Bafaloukos, P. Kosmidis et al. · Annals of Oncology · 2001 · 176 citations

Medicine, Oncology, Pharmacology +16

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study

Florentia Fostira, Marianthi Tsitlaidou, Christos Papadimitriou et al. · Breast Cancer Research and Treatment · 2012 · 119 citations

Life Sciences, Genetics, Oncology +16